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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: Uropathogenic Escherichia coli (UPEC) strains isolated from
patients with community-acquired urinary tract infections (UTIs) were assessed to determine
the prevalence of virulence genes, antibiotic resistance, and the O-serogroup of the strains.
Methods: Consenting patients with community-acquired UTI were enrolled at Unidad Me´dica
Familiar Number 64 (Instituto Mexicano del Seguro Social, Estado de Mexico, Mexico) and
321 urine samples were collected. Polymerase chain reaction (PCR) was used to assess 24 viru-
lence genes and 14 O-serogroups. The Kirby-Bauer method was used to evaluate the antibiotic
susceptibility of the isolated strains to 12 commonly used antibiotics.
Results: A total of 194 strains were identified as E. coli using standard biochemical tests, fol-
lowed by PCR amplification of 16S ribosomal RNA gene. Only 58.2% of the strains belonged to
the assessed 14 O-serogroups. The serogroups O25, O15, O8, and O75 were present in 20.6%,
17%, 6.1%, and 4.6% of strains, respectively. The most frequently occurring virulence genes
among UPEC strains included kpsMT (92.2% strains), usp (87.1%), irp2 (79.3%), iha (64.9%),
fim (61.3%), set (36%), astA (33.5%), pap (24.7%), and papGII (21.1%). In addition, 97% of the
strains were multi-drug resistant (coresistance to 3e11 antibiotics).la, Universidad Nacional Auto´noma de Me´xico. Avenida de Los Barrios 1, Los Reyes Iztacala,
o, Me´xico
com (S. Vaca).
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Escherichia coli strains isolated from
and Infection (2015), http://dx.doi.oConclusion: The isolated UPEC strains predominantly belonged to three serogroups (O25, O15,
and O8), harboured numerous virulence genes, and are multiresistant to antibiotics. The find-
ings of this study could be used to orient UTI treatment strategies and in epidemiological
studies in Mexico.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Urinary tract infection (UTI) is one of the most commonly
occurring bacterial infections1 and 70e95% of the UTIs are
caused by uropathogenic Escherichia coli (UPEC).2 Viru-
lence factors related to UPEC include genes encoding
adhesins (pap, papG allele I, papG allele II, papG allele III,
sfa, afaI, fim, iha, and tsh); genes related to the iron
acquisition systems (iuc, iroN, and irp2); protectin genes
(kpsMT and iss); and genes encoding toxins (set, astA cnf1,
hlyA, vat, usp, and cva/cvi).3,4
UPEC strains are routinely serotyped using the common
O antisera and the serogroups O1, O2, O4, O6, O7, O8, O15,
O16, O18, O21, O22, O25, O75, and O83 are preferentially
associated with UPEC strains.3,5 Serogroup assays are used
for accurate E. coli identification and for epidemiological
investigations of E. coli outbreaks.
The treatment of UTIs caused by UPEC often requires
antimicrobial therapy. However, currently there has been a
rise in the occurrence of antibiotic-resistant UPEC strains,
and UTIs are considered a serious health concern.1
Given the clinical importance of UTIs, the aim of this
work was to determine the prevalence of virulence genes,
resistance to antibiotics, and the O-serogroup of UPEC
strains isolated from patients with community-acquired
UTIs in Mexico.
Methods
Sample collection and E. coli strains
Three hundred and twenty-one urine samples were
collected from patients with community-acquired UTIs (247
women and 74 men; age range, 20e70 years) from Unidad
Me´dica Familiar (UMF) Number 64 (Instituto Mexicano del
Seguro Social), located in Estado de Mexico, Mexico, from
August 2013 to December 2013. Patient inclusion criteria
were as follows: persons with signs and symptoms of UTI
and accepting to participate in the study by signing the
informed consent letter were enrolled. Patients undergoing
antibiotic treatment were excluded. The local ethics
committee of UMF approved the study. The samples were
cultured on blood agar and MacConkey agar (Bioxon,
Mexico, Mexico) at 37C overnight. The identification of E.
coli was performed by IMViC tests, and confirmed by 16S
ribosomal RNA (rRNA) gene polymerase chain reaction
(PCR) amplification as described elsewhere.6,7 For each
test, E. coli ATCC 11775 was used as the control strain. An
UTI caused by E. coli was recognized if it was accompanied
by symptoms suggestive of infection and a culture of aniagua-Contreras GL, et al., Virule
community-acquired urinary tract
rg/10.1016/j.jmii.2015.08.005clean-catch urine sample with at least 105 colony forming
units of E. coli per milliliter.
DNA extraction
DNA extraction was performed using the boiling method.
Bacteria were grown in brain-heart infusion broth (BHI;
Bioxon) at 37C overnight. The bacterial overnight growth
culture (1.5 mL) was pelleted, the culture supernatant was
discarded, and the cell pellet was suspended in 200 mL of
sterile water. The resuspended pellet was then incubated
at 100C for 10 minutes and centrifuged at 10,000g for 5
minutes. The pellet was discarded and the DNA, present in
the supernatant, was stored at 20C until required for
assays.
Antibiotic susceptibility testing
The standard disc diffusion method of Kirby-Bauer by using
Mueller Hinton agar (Bioxon) was performed to evaluate
antibiotic susceptibility. The antibiotic susceptibility of
gram-negative bacteria was assessed by using 12 different
antibiotic-loaded discs (Bio-Rad, Mexico). Results were
interpreted in accordance with the Clinical and Laboratory
Standards Institute guidelines.8 The following antibiotics
were used at the indicated concentrations: ampicillin
(10 mg), cefalotin (30 mg), cefotaxime (30 mg), carbenicillin
(100 mg), ceftriaxone (30 mg), chloramphenicol (30 mg),
pefloxacin (5 mg), gentamicin (10 mg), nitrofurantoin
(300 mg), netilmicin (30 mg), amikacin (30 mg), and
trimethoprim-sulfamethoxazole (25 mg). For each test, E.
coli ATCC 11775 was used as the control strain. In accor-
dance with the manufacturer of the discs (Bio-Rad), strains
were considered resistant to carbenicillin if the diameter of
inhibition halo was  19 mm; and resistant to pefloxacin if
the diameter of inhibition halo was  14 mm.
Detection of virulence genes and serogroups of
UPEC strains
The primer sequences and PCR cycling conditions described
by Momtaz et al9 were used to assess the prevalence of the
following virulence genes: (1) adhesins: pap (pilus associ-
ated with pyelonephritis), papG allele I, papG allele II,
papG allele III, sfa (S fimbriae), afaI (afimbrial adhesin I),
fim (type-1 fimbriae), iha (nonhemagglutinating adhesin),
and tsh (temperature-sensitive hemagglutinin); (2) nutri-
tion: iuc (aerobactin), iroN (iron), and irp2 (iron-repress-
ible protein); (3) protectins: kpsMT (K-antigen) and iss
(increased serum survival protein); and (4) toxins: setnce factors, antibiotic resistance phenotypes and O-serogroups of
infection patients in Mexico, Journal of Microbiology, Immunology
Table 1 Virulence genes and serogroups of UPEC strains
UPEC serogrup
(n Z 194)
Adhesins
No. of strains
(%)
Nutrition Protectins Toxins she PAI
pap
48
(24.7)
papGl
23
(11.8)
papGll
41
(21.1)
papGlll
12
(6.2)
sfa
24
(12.3)
afa
25
(12.8)
fim
119
(61.3)
Iha
126
(64.9)
tsh
10
(5.1)
iuc
32
(16.5)
iroN
23
(11.8)
irp2
154
(79.3)
kpsMT
179
(92.2)
iss
7
(5.9)
astA
65
(33.5)
cnf1
14
(7.2)
hlyA
30
(15.4)
vat
11
(5.6)
usp
169
(87.1)
cva/cvi
9
(4.6)
set
70
(36)
sigA
8
(4.1)
sap
3
(1.5)
pic
5
(2.5)
No. (%)
01 5 (2.5) 1 d 3 1 1 1 4 3 d 1 2 4 4 d 3 1 1 d 4 d 3 d d d
02 1 (0.5) d d 1 d d d 1 1 d d d 1 1 d d d d d 1 d 1 d d d
04 0 (0) d d d d d d d d d d d d d d d d d d d d d d d d
06 2 (1.0) d 1 d 1 1 d d 2 d d 2 d 2 d 1 d d d 2 d d d d 2
07 1 (0.5) d d d d d d 1 d d d d 1 1 d d d d d 1 d d d d d
08 12 (6.1) 1 3 2 d 4 1 7 5 5 4 3 9 11 1 6 1 3 1 9 2 2 d 1 d
015 33 (17) 12 5 9 5 6 6 22 25 d 5 1 31 31 1 8 4 7 3 29 d 16 1 d d
016 7 (3.6) 1 2 1 d 1 d 5 5 d d 1 7 7 d 2 d 1 d 7 d 2 d d d
018 0 (0) d d d d d d d 5 d d d d d d d d d d d d d d d d
021 2 (1.0) d d d d 1 1 2 1 d d d 1 1 d 2 d d d 2 d d d d d
022 1 (0.5) d d d d d d d d d d d 1 1 d 1 d d d 1 d d d d d
025 40 (20.6) 18 4 19 1 8 7 30 39 3 11 2 36 40 1 13 5 14 1 34 1 21 4 1 d
075 9 (4.6) 2 4 d 1 d d 5 8 2 2 1 9 9 d 5 d d 2 5 2 6 d 1 d
083 0 (0) d d d d d d d d d d d d 0 d d d d d d d d d d d
Not
detected
81 (41.7) 13 4 6 3 12 d 42 32 0 9 11 54 71 4 24 3 4 d 74 4 19 3 0 3
UPEC Z uropathogenic Escherichia coli.
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Table 2 Antibiotic resistance of the UPEC strains
Antibiotic Number (%)
Cefalotin (Cf) 190 (97.9)
Ampicillin (Am) 189 (97.4)
Carbenicillin (Cb) 189 (97.4)
Pefloxacin (Pef) 148 (76.3)
Cefotaxime (Ctx) 141 (72.7)
Trimethoprim & sulfamethoxazole (Sxt) 128 (66.0)
Ceftriaxone (Cro) 95 (48.9)
Gentamycin (Ge) 97 (50.0)
Nitrofurantoin (Nf) 87 (44.8)
Netilmicin (Net) 72 (37.1)
Chloramphenicol (Cl) 50 (25.8)
Amikacin (Ak) 28 (14.4)
4 G.L. Paniagua-Contreras et al.
+ MODEL(Shigella enterotoxin 1), astA (enteroaggregative heat
stable toxin), cnf1 (cytotoxic necrotizing factor 1), hlyA
(hemolysin), vat (vacuolating autotransporter toxin), usp
(uropathogenic specific protein), and cva/cvi (colicin V
plasmid operon genes). To determine the presence of set
gene in the she pathogenicity island (she PAI), the sigA, pic,
and sap genes, which are also present in pathogenicity-
associated islands (PAIs), were detected using PCR as
described elsewhere.10
The primers and PCR conditions used for detection of
UPEC O1, O2, O4, O6, O7, O8, O15, O16, O18, O21, O22,
O25, O75, and O83 serogroups were described by Li et al.11
Statistical analysis
The frequencies of the virulence-related genes among the
serogroups of UPEC strains were analyzed using Chi-square
tests. A p value < 0.05 was considered significant.
Results
Detection of serogroups and virulence genes of
UPEC strains
A total of 194 strains isolated from patients with
community-acquired UTIs were identified as E. coli by using
standard biochemical tests and the identity was confirmed
using PCR amplification of the 16S rRNA gene. Only 58.2%
(n Z 113) of the strains belonged to 11 of the 14 assessed
serogroups (Table 1). The serogroups O25, O15, O8, and O75
were prevalent in 20.6% (40), 17% (33), 6.1% (12), and 4.6%
(9) isolated UPEC strains, respectively (Table 1).
The adhesion genes with the highest prevalence were
iha (64.9%, n Z 126), fim (61.3%, n Z 119), and pap
(24.7%, n Z 48). The iron acquisition genes irp2 and iuc
were present in 79.3% (154) and 16.5% (32) of the isolated
UPEC strains, respectively. The most commonly present
gene for host defense avoidance was the capsular poly-
saccharide production related gene, kpsMT (92.2%,
n Z 179). The toxin-coding genes usp, set, astA, and hlyA
were present in 87.1% (169), 36% (70), 33.5% (65), and
15.4% (30) strains, respectively. The she PAI-associated
sigA, sap, and pic genes were found in a very low num-
ber of the strains (Table 1).
UPEC strains belonging to serogroups O25 (20.6%,
n Z 40), O15 (17%, n Z 33), and O8 (6.1%, n Z 12)
harbored the highest number of associated virulence fac-
tors (Table 1).
The virulence gene frequencies among the serogroups of
UPEC strains were different (p < 0.05).
Multidrug resistance
Almost 98% of the UPEC strains were resistant to cefalotin
(97.9%, n Z 190), ampicillin (97.4%, n Z 189), or carbeni-
cillin (97.4%, n Z 189). Seventy-six percent of strains
(nZ 148) were resistant to pefloxacin and 72.7% (nZ 141)
strains were resistant to cefotaxime (Table 2). Overall, a
total of 188 strains (96.9%) were resistant to three to 11
antibiotics (Table 3).Please cite this article in press as: Paniagua-Contreras GL, et al., Virule
Escherichia coli strains isolated from community-acquired urinary tract
and Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.08.005Patterns of virulence genotypes, antibiotic
resistance phenotypes, and serogroup of the UPEC
strains
A total of 138 distinct arrangements of antibiotic resistance
phenotypes and virulence markers were identified in the
UPEC strains. None of the patterns was predominantly
prevalent (Table 3). The most abundant pattern (No. 1;
fim/iha/irp2/kpsMT/usp/set/cefalotin/ampicillin/carbe-
nicillin) was represented only by 11 strains (5.6%) that
belonged to serogroups O25 (6 strains), O15 (1 strain), O75
(1 strain), and to O-serogroup not assessed in this study (3
strains).Discussion
Recently, several different prevalence rates of UPEC strains
related to UTIs have been described in different
countries.12e14 Furthermore, the antibiotic resistance of
UPEC strains is of increasing public health concern.15 In this
study, we identified E. coli in 60.4% (n Z 194) of the 321
urine samples obtained from patients with community-
acquired UTIs. Unlike diarrheagenic E. coli strains that
have been classified into six different pathotypes,16 UPEC
strains are genetically more diverse and may share viru-
lence determinants with diarrheagenic E. coli.3 Four
serogroups (O25, O15, O8, and O75) were predominantly
prevalent among the UPEC strains assessed in this study. It
has been previously reported that 025 was the most
frequent serotype found in uropathogenic E. coli in Mexico
City.17
Genes encoding fimbrial adhesive systems are the most
commonly occurring virulence factors in E. coli that cause
UTIs.18 The adhesion factors promote colonization, inva-
sion, and replication within uroepithelial cells19 and pre-
cede the expression of other bacterial products such as
toxins, iron acquisition systems, and host defense avoid-
ance mechanisms (protectins), which are encoded on
PAIs.20 The most prevalent adhesion genes found in our
study were iha (64.9%, nZ 126), fim (61.3%, nZ 119), pap
(24.7%, n Z 48), and papGII (21.1%, n Z 41; Table 1). The
adhesion genes were mainly associated with serogroups
O25, O15, and O8 (Table 1). These findings are in agreementnce factors, antibiotic resistance phenotypes and O-serogroups of
infection patients in Mexico, Journal of Microbiology, Immunology
Table 3 Patterns of virulence genes, antibiotic resistance phenotypes, and O-serogroup of the UPEC strains
Number
of pattern
Patterns of virulence genes and antibiotic resistance phenotypes Serogroups Number
of strains
%
01 02 04 06 07 08 015 016 018 021 022 025 075 083 Not
detected
1 fim/iha/irp2/kpsMT/usp/set/Cf/Am/Cb d d d d d d 1 d d d d 6 1 d 3 11 5.6
2 fim/iha/irp2/kpsMT/usp/astA/Cf/Am/Cb d d d d d d 1 d d 1 d 2 1 d 4 9 4.6
3 fim/iha/iuc/irp2/kpsMT/usp/set/Cf/Am/Ctx/Pef/Cb d d d d d d 1 d d d d 2 d d 4 7 3.6
4 fim/iha/irp2/kpsMT/usp/astA/set/Cf/Am/Cb d d d d d d 1 d d d d 4 1 d 0 6 3.1
5 fim/irp2/set/Cf/Am/Cb d d d d d d d d d d d 1 d d 4 5 2.5
6 fim/irp2/astA/set/Cf/Am/Cb d d d d d d 1 d d d d d d d 3 4 2.0
7 fim/papGl/iha/irp2/kpsMT/usp/set/Cf/Am/Ctx/Cb d d d d d d 1 1 d d d d 2 d 0 4 2.0
8 fim/iha/irp2/kpsMT/usp/Cf/Am/Cb d d d d d d 3 d d d d 1 d d 0 4 2.0
9 pap/iha/irp2/kpsMT/usp/set/Cf/Cro/Am/Sxt/Ctx/Net/Pef/Ge/Cb d d d d d d 2 1 d d d d d d 0 3 1.5
10 fim/irp2/kpsMT/astA/Cf/Am/Cb d d d d d d d d d d d d d d 3 3 1.5
11 pap/papGII/sfa/fim/iha/irp2/kpsMT/cnf1/hlyA/usp/Cf/Am/Net/Pef/Ge/Cb d d d d d d 2 d d d d d d d 0 2 1.0
12 sfa/hlyA/set/Cf/Cro/Am/Sxt/Ctx/Pef/Nf/Ge/Cb d d d d d d d d d d d 1 d d 1 2 1.0
13 hlyA/fim/set/irp2/Cf/Am/Ctx/Pef/Cb d d d d d d d 1 d d d d d d 1 2 1.0
14 afa/fim/astA/Cf/Am/Ctx/Pef/Nf/Cb d d d d d 1 d d d d d d d d 1 2 1.0
15 papGI/sfa/fim/iha/irp2/kpsMT/hlyA/usp/Am/Pef/Cb d d d d d 1 d d d d d 1 d d 0 2 1.0
16 fim/iha/iroN/irp2/kpsMT/cva-cv1/Cf/Am d d d d d 1 d d d d d d 1 d 0 2 1.0
17 pap/papGII/iha/irp2/kpsMT/usp/Cf/Am/Cb d d d d 1 d d d d d d 1 d d 0 2 1.0
18e138 Other combinations 5 1 0 2 0 9 20 4 0 1 1 21 3 0 57 124 64.0
Ak Z amikacin; Am Z ampicillin, Cb Z carbenicillin, Cf Z cefalotin, Cl Z chloramphenicol; Cro Z ceftriaxone, Ctx Z cefotaxime, Ge Z gentamycin, Net Z netilmicin;
Nf Z nitrofurantoin, Pef Z pefloxacin, Sxt Z trimethoprim and sulfamethoxazole; UPEC Z uropathogenic Escherichia coli.
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+ MODELwith those previously reported for UPEC strains (n Z 162)
isolated from cystitis21 and for UPEC strains (n Z 202)
isolated from patients with community-acquired UTIs.22
The fim, pap, sfa, and afa genes have been associated
with cystitis and pyelonephritis.23 Previous studies have
shown that papGII is associated with pyelonephritis and
bacteraemia and that class papGIII is associated with
cystitis; although strains associated with pyelonephritis and
bacteraemia have also been shown to harbor papGIII
genes.24,25 In this study, iha was the most frequent adhe-
sion gene detected in the UPEC strains (Table 1). It has
been described that iha confers nonadherent E. coli K12
adherence capability to Hela cells, and the encoded protein
(Iha) was first identified from an E. coli O157:H7 isolate.26
In this study the iron acquisition system genes, irp2
(79.3%, nZ 154) and iuc (16.5%, nZ 32; Table 1), were the
most prevalent in the serogroups O25, O15, and O8. The
prevalence rates obtained in our study were higher than
those previously described for UPECs,27 but lower than
those described for avian pathogenic E. coli, indicating that
frequencies of iron acquisition system genes vary according
to location and host.28 Iron is an essential element for the
survival of E. coli and facilitates numerous cellular activ-
ities such as peroxide reduction, electron transport, and
nucleotide biosynthesis.29
High prevalence of virulence markers in the UPEC strains
isolated from patients with community-acquired UTIs sug-
gests that these strains are highly pathogenic. The capsule-
encoding gene, kpsMT, is commonly prevalent in UPEC
strains associated with pyelonephritis than in strains asso-
ciated with other UTIs.30 In this study, > 92% (179) of the
isolated strains were positive for kpsMT (Table 1).
Furthermore, the percentage of strains with toxin-coding
genes usp, set, astA, and hlyA were 87.1%, 36%, 33.5%,
and 15.4%, respectively. These data indicated that the
isolated strains have the potential to produce toxins.
Different gene prevalence frequencies have been described
for UPECs isolated in other countries.21,22,31 Other virulence
genes that were detected in UPECs were as follows: usp,
which has been shown to occur more frequently in strains
associated with pyelonephritis than with cystitis32; set
encoding the ShET-1 (Shigella enterotoxin 1) toxin that has
been shown to induce fluid accumulation in the rabbit ileal
loop and may account for initial watery diarrhea that can
occur in early stages of Shigella flexneri 2a infections33;
astA encoding the EAST-1 (enteroaggregative heat-stable
toxin 1) toxin that plays a role in enteroaggregative E.
coli (EAEC) pathogenicity34 and hlyA in UPEC increased
urothelial damage in vivo.35
The emergence of E. coli isolates that have multiple-
antibiotic-resistant phenotypes, which confers resistance
to four or more unrelated families of antibiotics has been
previously reported and is considered a serious health
concern.36,37 Most UPEC strains that were characterized in
this study were resistant to cefalotin, ampicillin, carbeni-
cillin, pefloxacin, and cefotaxime (Table 2), with 96.9%
(n Z 188) of strains showing multi-drug resistance (core-
sistance to 3e11 antibiotics). This finding is in agreement
with previous findings on antibiotic resistance of UPEC
strains isolated from patients from other countries.22 The
high prevalence of multiple-antibiotic resistance in UPECs
may be related with the frequent use of these drugs toPlease cite this article in press as: Paniagua-Contreras GL, et al., Virule
Escherichia coli strains isolated from community-acquired urinary tract
and Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.08.005treat UTIs in Mexico. Of particular concern is the finding
that a high percentage of E. coli strains are resistant to
trimethoprim/sulfamethoxazole (66%) and nitrofurantoin
(44.8%) because these antibiotics, and ciprofloxacin, are
the therapeutic agents used in the Mexican social security
health system, Instituto Mexicano del Seguro Social, to
treat UTIS.
The transfer of resistance determinants by mobile ge-
netic elements, including plasmids, transposons, and gene
cassettes present in integrons38 and the alteration in mar
locus regulation may be important factors that can
contribute to the increase in the prevalence of multidrug-
resistant bacteria.
In this study, different patterns of combinations of the
virulence markers and antibiotic resistant phenotypes were
identified in the UPEC strains (Table 3). All the strains from
patterns 1e4, 7e11, and 15e17 (36%, nZ 70) had genes for
adhesins, nutrition, protectins, toxins, and resistance to
cefalotin, ampicillin, and carbenicillin (resistance to 1 of
the aforementioned antibiotics was absent in strains with
patterns 15 and 16), and mainly belonged to serogroups
O15, O25, and O8. The pattern 1 (fim/iha/irp2/kpsMT/usp/
set/cefalotin/ampicillin/carbenicillin) was the most
frequently present (Table 3). The association between fimA
and kpsMT genes that was identified in our study was pre-
viously characterized using E. coli isolated from UTIs and
asymptomatic bacteriuria in children.31 In this study we
found that genes fim and kpsMT were present in a high
percentage of the E. coli strains (57.7%, n Z 110, data not
shown). The simultaneous possession of these genes may
enhance the pathogenesis of E. coli due to the increased
adhesion (fimbriae encoded by fim) and the evasion of
phagocytosis (capsule encoded by kpsMT ).
In conclusion, to our knowledge, in addition to the work
of Molina-Lo´pez et al,17 this is the second comprehensive
study that characterizes the genotype of uropathogenic E.
coli in Mexico. The strains characterized here showed the
coexistence of different combinations of virulence markers
and confirmed the prevalence of antibiotic-resistant phe-
notypes among the distinct serogroups. The findings of our
study have potential application in designing UTI treatment
strategies against UTIs caused by E. coli and for epidemi-
ological studies in Mexico.
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